DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Asacol (Mesalamine) - Current Clinical Trials

 
 



Asacol Related Clinical Trials

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis [Completed]

Pharmacokinetics of Asacol 2.4 g/Day and Lialda 2.4 g/Day in Healthy Volunteers [Completed]

The Colitis Once Daily Asacol Study [Completed]

Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis [Terminated]

The Effect of Long-Acting Mesalamine on Post-Infective Irritable Bowel Syndrome- A Pilot Study [Recruiting]

Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis [Completed]

Efficacy of Mesalamine in Diarrhea-predominant Irritable Bowel Syndrome (dIBS) [Completed]

Preventing Postoperative Relapse in Crohn's Disease Patients at Risk: Azathioprine Versus Mesalazine [Completed]

Mesalazine 4g Once Daily Versus 4g in Two Divided Doses in Active Ulcerative Colitis. [Completed]

Canadian Active & Maintenance Modified Pentasa Study [Completed]

Once Daily (OD) Versus Three Times Daily (TID) Dosing With Mesalazine Granules for Prevention of Recurrence of Ulcerative Colitis (UC) [Completed]

Study of the Safety and Tolerability of ALTH12 Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis [Completed]

Correlation of Mesalamine Pharmacokinetics With Local Availability [Active, not recruiting]

Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients [Terminated]

Effects of Mesalamine and Amitriptyline on Irritable Bowel Syndrome [Recruiting]

Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis [Completed]

Asacol Dosing Study for Active Ulcerative Colitis [Completed]

Cimzia Versus Mesalamine for Crohn's Recurrence [Recruiting]

Curcumin + Aminosalicylic Acid (5ASA) Versus 5ASA Alone in the Treatment of Mild to Moderate Ulcerative Colitis [Completed]

A BE Study Comparing Mesalamine 400 mg to ASACOL� 400 mg in Patients With Mild To Moderately Active Ulcerative Colitis [Completed]

A Randomized Controlled Pilot Trial of Mesalazine in Patients With Irritable Bowel Syndrome [Completed]

Mechanistic Randomized Controlled Trial (RCT) of Mesalazine in Symptomatic Diverticular Disease [Completed]

Ciprofloxacin XR Drug Interaction Study With MMX® Mesalazine/Mesalamine [Completed]

Comparative Efficacy and Safety Study in Patients With Active Ulcerative Colitis [Completed]

Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission Phase [Completed]

Sulfamethoxazole Drug Interaction Study With MMX� Mesalazine/Mesalamine [Completed]

An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension Phase [Recruiting]

Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC) [Not yet recruiting]

Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC) [Not yet recruiting]

Mesalamine Pellet Formulation to Maintain Remission of Mild to Moderate Ulcerative Colitis [Completed]

Mesalamine 4 gm/60 mL Rectal Enema [Completed]

Amoxicillin Drug Interaction Study With MMX� Mesalazine/Mesalamine [Completed]

Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea [Completed]

Mesalazine Therapy in Patients With Irritable Bowel Syndrome [Completed]

Casein Glycomacropeptide in Active Distal Ulcerative Colitis (Pilot Study) [Completed]

Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis [Recruiting]

QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa®) [Not yet recruiting]

Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis [Completed]

A Study With Pentasa in Patients With Active Crohn's Disease [Terminated]

Mesalamine to Reduce T Cell Activation in HIV Infection [Completed]

Phosphatidylcholine (LT-02) vs. Placebo vs. Mesalamine for Maintenance of Remission in Ulcerative Colitis (PROTECT-2) [Recruiting]

Targeting Oxidative Stress in Chronic Beryllium Disease [Completed]

TP05 for the Treatment of Mild to Moderate Active UC [Active, not recruiting]

PK Study of Encapsulated Mesalamine Granules in Healthy Volunteers [Completed]

Clinical Trial With Mesalamine 1g Suppositories [Terminated]

Mesalamine Pellet to Maintain Remission of Mild to Moderate Ulcerative Colitis [Completed]

Budesonide vs. Mesalazine vs. Budesonide/Mesalazine Suppository Combination Therapy in Acute Ulcerative Proctitis [Recruiting]

Comparison Azathioprine to Mesalazine for the Prevention of Postoperative Recurrence in the Crohn Disease [Completed]

A Double Blind Study for the Treatment of Acute Ulcerative Colitis [Completed]

Bioavailability Study of Two Mesalamine 4 gm/60 ml Rectal Enema Formulations [Completed]

The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease" [Terminated]

Mesalazine (PENTASA®) in Ulcerative Colitis [Completed]

Mesalazine for the Treatment of Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D) [Completed]

Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission [Completed]

Evaluation of Efficacy of Mesalamine in the Long-term Prevention of Diverticulitis Flares [Completed]

Budesonide Versus Mesalazine Versus Placebo in Lymphocytic Colitis [Recruiting]

Evaluation of the Metabolome in Diverticular Disease [Recruiting]

Taste Assessment Study of SHP429 in Healthy Adult Subjects [Completed]

Observational Study in the Management of Ulcerative Colitis With Oral 5-ASA [Completed]

Two Doses Mesalazine Granules Versus Placebo for the Prevention of Recurrence of Diverticulitis [Terminated]

TID 1000 mg Mesalazine Versus TID 2x500 mg Mesalazine in Active Ulcerative Colitis (UC) [Active, not recruiting]

Dose Escalation and Remission (DEAR) [Completed]

Induction and Maintenance of Remission With Pentasa as Ulcerative Colitis Treatment [Recruiting]

Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (P05553 AM2) [Terminated]

A Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tablets in Children With Crohn´s Disease [Completed]

Adherence to Mesalamine Profile for Patients With Inflammatory Bowel Disease [Completed]

Pharmacokinetics of IBD98-M 400mg-57.5/Day in Healthy Volunteers [Completed]

Mesalazine Granules vs. Placebo for the Prevention of Recurrence of Diverticulitis [Terminated]

Oral Budesonide vs. Oral Mesalazine in Active Crohn's Disease (CD) [Completed]

Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis [Completed]

OD vs. TID Dosing With Mesalazine Granules in Active Ulcerative Colitis [Completed]

Standardized Fecal Microbiota Transplantation for Inflammatory Bowel Disease [Recruiting]

Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis [Terminated]

Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission [Completed]

Phase II Dose-Ranging Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476 [Completed]

Trial of Mesalamine for the Treatment of Active Microscopic Colitis [Completed]

Effect of GSK1399686 in Patients With Mild to Moderately Active Ulcerative Colitis [Completed]

Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC) [Active, not recruiting]

A Phase II Study to Explore the Safety and Activity of Dersalazine in Patients With Mild to Moderate Ulcerative Colitis [Completed]

Clinical Management of Childhood Intestinal Lymphoid Nodular Hyperplasia [Recruiting]

Prevention of Recurrence of Diverticulitis [Completed]

Safety and Efficacy of SPD476 (Mesalazine) Given Twice Daily (2.4 g/Day) vs SPD476 Given as a Single Dose (4.8 g/Day) in Subjects With Acute Mild to Moderate Ulcerative Colitis [Completed]

TP0501 - Pharmaco-Scintigraphic-Study [Completed]

Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome [Withdrawn]

Standardized Fecal Microbiota Transplantation for Crohn&Apos;s Diseases [Recruiting]

Study of Effects and of Modifications in Apoptosis Regulators Observed After Stopping 5-ASA Treatment in Patients With Inactive Ulcerative Colitis [Terminated]

Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis [Completed]

Mesalamine and Reproductive Health Study [Recruiting]

A Study of Pentasa in Patients With Ulcerative Colitis [Completed]

Randomized Placebo Controlled Trial of Budesonide Multi-Matrix System (MMX®) 9 mg in Patients With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA). [Completed]

TP0502-B-Pharmaco-Scintigraphic-Study [Completed]

TP0502-Pharmaco-Scintigraphic-Study and Amendment [Completed]

Safety and Tolerability of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis. [Completed]

A Study to Investigate the Efficacy of LT-02 in Patients With Mesalazine Refractory Ulcerative Colitis [Active, not recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015